Skip to main content

Advertisement

SpringerLink
Log in

Combination of Sjögren’s syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature

  • CASE BASED REVIEW
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The frequency of antibodies to Ku varies in various autoimmune diseases. In 2019, Spielmann et al. identified two types of anti-Ku syndrome based on a hierarchical clustering analysis. Sjögren’s syndrome occurs both in the first type of anti-Ku syndrome and in the second type. Despite the fact that increased tissue expression of Ku proteins was noted in lymphocytic cells with focal sialoadenitis of the minor salivary glands in patients with primary Sjogren’s syndrome, only 49 cases of a combination of anti-Ku antibodies and manifestations of Sjogren’s syndrome have been described in the literature. Some researchers examined patients for the presence of Sjogren’s syndrome only if they had anti-Ro or anti-La antibodies, although in the literature, there are descriptions of Sjogren’s syndrome in the presence of only isolated anti-Ku antibodies, as in our case. Literature data on glandular and extraglandular manifestations of Sjögren’s syndrome in anti-Ku-positive patients are limited. Below, we present the first case of Sjögren’s syndrome in combination with the first type of anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue (MALT) lymphoma. The article also provides a systematic review of the literature on the association of Sjögren’s syndrome with anti-Ku antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Smider V, Rathmell WK, Lieber MR, Chu G (1994) Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 266(5183):288–291. https://doi.org/10.1126/science.7939667

    Article  CAS  PubMed  Google Scholar 

  2. Iuchi K, Yagura T (2016) DNA binding activity of Ku during chemotherapeutic agent-induced early apoptosis. Exp Cell Res 342(2):135–144. https://doi.org/10.1016/j.yexcr.2016.03.011

    Article  CAS  PubMed  Google Scholar 

  3. Soubeyrand S, Schild-Poulter C, Haché RJ (2004) Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18. Eur J Biochem 271(18):3776–3784. https://doi.org/10.1111/j.1432-1033.2004.04319.x

    Article  CAS  PubMed  Google Scholar 

  4. Fredi M, Cavazzana I, Quinzanini M, Taraborelli M, Cartella S, Tincani A, Franceschini F (2014) Rare autoantibodies to cellular antigens in systemic lupus erythematosus. Lupus 23(7):672–677. https://doi.org/10.1177/0961203314524850

    Article  CAS  PubMed  Google Scholar 

  5. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Tonello M, Bendo R, Rondinone R, Cozzi F, Doria A (2005) Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: studio sierologico di 46 pazienti [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients]. Reumatismo 57(1):22–8. https://doi.org/10.4081/reumatismo.2005.22

    Article  CAS  PubMed  Google Scholar 

  6. Selva-O’Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55(5):791–798. https://doi.org/10.1002/art.22237

    Article  PubMed  Google Scholar 

  7. Rozman B, Cucnik S, Sodin-Semrl S, Czirjak L, Varju C, Distler O, Huscher D, Aringer M, Steiner G, Matucci-Cerinic M, Guiducci S, Stamenkovic B, Stankovic A, Kveder T (2008) Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Ann Rheum Dis 67(9):1282–1286. https://doi.org/10.1136/ard.2007.073981

    Article  CAS  PubMed  Google Scholar 

  8. Hoa S, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ, Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS) (2016) Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations. Medicine (Baltimore) 95(35):e4713. https://doi.org/10.1097/MD.0000000000004713

    Article  CAS  PubMed  Google Scholar 

  9. Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthymiou G, Scheper T, Meyer W, Bogdanos DP, Sakkas LI (2017) Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity 50(7):414–421. https://doi.org/10.1080/08916934.2017.1357699

    Article  CAS  PubMed  Google Scholar 

  10. Leurs A, Dubucquoi S, Machuron F, Balden M, Renaud F, Rogeau S, Lopez B, Lambert M, Morell-Dubois S, Maillard H, Béhal H, Hachulla E, Launay D, Sobanski V (2021) Extended myositis-specific and -associated antibodies profile in systemic sclerosis: a cross-sectional study. Joint Bone Spine. 88(1):105048. https://doi.org/10.1016/j.jbspin.2020.06.021

    Article  CAS  PubMed  Google Scholar 

  11. Spielmann L, Nespola B, Séverac F, Andres E, Kessler R, Guffroy A, Poindron V, Martin T, Geny B, Sibilia J, Meyer A (2019) Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes. Ann Rheum Dis 78(8):1101–1106. https://doi.org/10.1136/annrheumdis-2018-214439

    Article  CAS  PubMed  Google Scholar 

  12. Ogawa-Momohara M, Muro Y, Akiyama M (2019) Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2019-216375

  13. Rigolet A, Musset L, Dubourg O, Maisonobe T, Grenier P, Charuel JL, Behin A, Herson S, Amoura Z, Benveniste O (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) 91(2):95–102. https://doi.org/10.1097/MD.0b013e31824d9cec

    Article  CAS  PubMed  Google Scholar 

  14. Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, Doria A, Cattaneo R (2002) Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 29(7):1393–1397

    PubMed  Google Scholar 

  15. Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Airò P, Cattaneo R, Franceschini F (2008) Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus 17(8):727–732. https://doi.org/10.1177/0961203308089442

    Article  CAS  PubMed  Google Scholar 

  16. Mendes PA, Ferreira DM, Temido H, Pina R, de Carvalho A (2018) Mesenteric panniculitis in Sjögren’s syndrome: a new systemic manifestation to consider? Eur J Case Rep Intern Med. 5(4):000788. https://doi.org/10.12890/2018_000788

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rönnelid J, Barbasso Helmers S, Storfors H, Grip K, Rönnblom L, Franck-Larsson K, Nordmark G, Lundberg IE (2009) Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9(1):58–61. https://doi.org/10.1016/j.autrev.2009.03.005

    Article  CAS  PubMed  Google Scholar 

  18. Moore J, Mahajan A, Gajjala S, Makkar P (2021) A Case of Progressive Dyspnea: Lymphocytic Interstitial Pneumonia in Collagen Vascular Disease. Cureus 13(10):e18427. https://doi.org/10.7759/cureus.18427

    Article  PubMed  PubMed Central  Google Scholar 

  19. Yamamoto AM, Amoura Z, Johannet C, Jeronimo AL, Campos H, Koutouzov S, Piette JC, Bach JF (2000) Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Arthritis Rheum 43(3):689–698. https://doi.org/10.1002/1529-0131(200003)43:3%3c689::AID-ANR27%3e3.0.CO;2-U

    Article  CAS  PubMed  Google Scholar 

  20. Jardel S, Fabien N, Hot A, Vukusic S, Tebib J, Cottin V, Sève P, Laville M, Belot A, Durieu I, Garnier L, Coutant F, Reynaud Q, Lega JC (2017) Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: results from a routine population survey. PLoS One 12(9):e0185104. https://doi.org/10.1371/journal.pone.0185104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gryga K, Milewski M, Zółciński M, Dyczek A, Musiał J (2009) Anti-Ku autoantibodies: series of 5 cases. Pol Arch Med Wewn. 119(1–2):95–7. https://doi.org/10.20452/pamw.616

    Article  PubMed  Google Scholar 

  22. Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F (2013) A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. Clin Exp Rheumatol. 31(2 Suppl 76):118–21

    PubMed  Google Scholar 

  23. Lakota K, Thallinger GG, Sodin-Semrl S, Rozman B, Ambrozic A, Tomsic M, Praprotnik S, Cucnik S, Mrak-Poljsak K, Ceribelli A, Cavazzana I, Franceschini F, Vencovsky J, Czirják L, Varjú C, Steiner G, Aringer M, Stamenkovic B, Distler O, Matucci-Cerinic M, Kveder T (2012) International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis. Arthritis Res Ther 14(1):R2. https://doi.org/10.1186/ar3550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Yaneva M, Arnett FC (1989) Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol. 76(3):366–7

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Schild-Poulter C, Su A, Shih A, Kelly OP, Fritzler MJ, Goldstein R, Haché RJ (2008) Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases. Rheumatology (Oxford) 47(2):165–171. https://doi.org/10.1093/rheumatology/kem338

    Article  CAS  PubMed  Google Scholar 

  26. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O’Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) (2017) 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 76(12):1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468

    Article  PubMed  Google Scholar 

  27. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 69(1):35–45. https://doi.org/10.1002/art.39859

    Article  PubMed  Google Scholar 

  28. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013Nov) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747–1755. https://doi.org/10.1136/annrheumdis-2013-204424

    Article  PubMed  Google Scholar 

  29. Larsson Å, Henriksson G, Manthorpe R, Sallmyr A, Bredberg A. Ku protein and DNA strand breaks in lip glands of normal and primary Sjögren’s syndrome subjects: lack of correlation with apoptosis. Scand J Immunol, 54(3), 328–334. https://doi.org/10.1046/j.1365-3083.2001.00978.x

  30. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M (1981) Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 68(3):611–620. https://doi.org/10.1172/jci110295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gofrit SG, Yonath H, Lidar M, Shoenfeld Y, Kivity S (2018) The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders. Clin Rheumatol 37(5):1257–1263. https://doi.org/10.1007/s10067-018-4032-3

    Article  CAS  PubMed  Google Scholar 

  32. Yang, H., Li, W., Tian, X., Wang, G., Shu, X., Peng, Q., & Lu, X. (2020). Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217106

  33. Ottewill C, Aamir S, Nash D, Dunne R, Redmond K, Fabre A, Durcan L, Keogan M, Hurley K (2020) Isolated interstitial lung disease associated with anti-Ku autoantibodies: a case responding to a CD20 inhibitor. QJM, hcaa227. https://doi.org/10.1093/qjmed/hcaa227.

  34. Otoshi R, Yamakawa H, Takemura T, Katano T, Aiko N, Matama G, Isomoto K, Baba T, Hagiwara E, Ogura T (2018) Anti-Ku antibody-positive desquamative interstitial pneumonia. Respir Med Case Rep 16(26):115–117. https://doi.org/10.1016/j.rmcr.2018.12.007

    Article  Google Scholar 

  35. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66(10):1345–1349. https://doi.org/10.1136/ard.2006.068502

    Article  PubMed  PubMed Central  Google Scholar 

  36. Hausmanowa-Petrusewicz I, Kowalska-Olędzka E, Miller FW et al (1997) Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 40:1257–1266

    Article  CAS  PubMed  Google Scholar 

  37. Campochiaro C, De Luca G, De Santis M (2021) Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis. Ann Rheum Dis 80(7):e113. https://doi.org/10.1136/annrheumdis-2019-216070

    Article  PubMed  Google Scholar 

  38. Rodriguez-Reyna TS, Hinojosa-Azaola A, Martinez-Reyes C, Nuñez-Alvarez CA, Torrico-Lavayen R, García-Hernández JL, Cabiedes-Contreras J (2011) Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients. Autoimmunity 44(7):576–584. https://doi.org/10.3109/08916934.2011.592886

    Article  CAS  PubMed  Google Scholar 

  39. Spielmann L, Séverac F, Meyer A (2019) The heart of anti-Ku related disease: extensive review and meta-analysis. Response to: 'Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis' by Campochiaro et al. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2019-216095

  40. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84(4):231–249. https://doi.org/10.1097/01.md.0000173991.74008.b0

    Article  PubMed  Google Scholar 

  41. Váncsa A, Gergely L, Ponyi A, Lakos G, Németh J, Szodoray P, Dankó K (2010) Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine 77(2):125–130. https://doi.org/10.1016/j.jbspin.2009.08.008

    Article  CAS  PubMed  Google Scholar 

  42. Kono M, Komai T, Yuki H, Hanata N, Kakumoto T, Kubota A, Maeda MH, Toda T, Shoda H, Fujio K (2022) Anti-Ku antibody-positive myositis presenting as a wide range of axial myopathies and myocarditis: a case report and review of the literature. Modern Rheumatology Case Reports 6(1):64–68. https://doi.org/10.1093/mrcr/rxab024

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Department, Moscow City Hospital №52, Moscow, Russia

    Oksana Andreevna Golovina

  2. Department of Intensive Methods of Therapy, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

    Anna Vasilievna Torgashina, Vadim Romanovich Gorodetskiy & Evgenia Vladimirovna Sockol

  3. Rheumatology Department №5, V. A. Nasonova Research Institute of Rheumatology, Moscow, Russia

    Elena Georgievna Sagina

Authors
  1. Oksana Andreevna Golovina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Vasilievna Torgashina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vadim Romanovich Gorodetskiy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Evgenia Vladimirovna Sockol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elena Georgievna Sagina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oksana Andreevna Golovina.

Ethics declarations

Conflict of interest

The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Golovina, O.A., Torgashina, A.V., Gorodetskiy, V.R. et al. Combination of Sjögren’s syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature. Clin Rheumatol 43, 2145–2152 (2024). https://doi.org/10.1007/s10067-024-06966-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-024-06966-9

Keywords

Search

Navigation